These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 25680271)

  • 41. CRISPR screen in regulatory T cells reveals modulators of Foxp3.
    Cortez JT; Montauti E; Shifrut E; Gatchalian J; Zhang Y; Shaked O; Xu Y; Roth TL; Simeonov DR; Zhang Y; Chen S; Li Z; Woo JM; Ho J; Vogel IA; Prator GY; Zhang B; Lee Y; Sun Z; Ifergan I; Van Gool F; Hargreaves DC; Bluestone JA; Marson A; Fang D
    Nature; 2020 Jun; 582(7812):416-420. PubMed ID: 32499641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. De novo-induced self-antigen-specific Foxp3+ regulatory T cells impair the accumulation of inflammatory dendritic cells in draining lymph nodes.
    Alissafi T; Hatzioannou A; Ioannou M; Sparwasser T; Grün JR; Grützkau A; Verginis P
    J Immunol; 2015 Jun; 194(12):5812-24. PubMed ID: 25948818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
    Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
    J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity.
    Hu W; Wang ZM; Feng Y; Schizas M; Hoyos BE; van der Veeken J; Verter JG; Bou-Puerto R; Rudensky AY
    Nat Immunol; 2021 Sep; 22(9):1163-1174. PubMed ID: 34426690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulatory T cells modulate postischemic neovascularization.
    Zouggari Y; Ait-Oufella H; Waeckel L; Vilar J; Loinard C; Cochain C; Récalde A; Duriez M; Levy BI; Lutgens E; Mallat Z; Silvestre JS
    Circulation; 2009 Oct; 120(14):1415-25. PubMed ID: 19770391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity.
    Wang D; Quiros J; Mahuron K; Pai CC; Ranzani V; Young A; Silveria S; Harwin T; Abnousian A; Pagani M; Rosenblum MD; Van Gool F; Fong L; Bluestone JA; DuPage M
    Cell Rep; 2018 Jun; 23(11):3262-3274. PubMed ID: 29898397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An obligate cell-intrinsic function for CD28 in Tregs.
    Zhang R; Huynh A; Whitcher G; Chang J; Maltzman JS; Turka LA
    J Clin Invest; 2013 Feb; 123(2):580-93. PubMed ID: 23281398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells.
    Massoud AH; Guay J; Shalaby KH; Bjur E; Ablona A; Chan D; Nouhi Y; McCusker CT; Mourad MW; Piccirillo CA; Mazer BD
    J Allergy Clin Immunol; 2012 Jun; 129(6):1656-65.e3. PubMed ID: 22564681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
    Kaur G; Goodall JC; Jarvis LB; Hill Gaston JS
    Mol Immunol; 2010; 48(1-3):321-32. PubMed ID: 20688398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.
    Fenoglio D; Ferrera F; Fravega M; Balestra P; Battaglia F; Proietti M; Andrei C; Olive D; Antonio LC; Indiveri F; Filaci G
    Hum Immunol; 2008 Nov; 69(11):745-50. PubMed ID: 18832002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human FOXP3
    Wing JB; Tanaka A; Sakaguchi S
    Immunity; 2019 Feb; 50(2):302-316. PubMed ID: 30784578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resting B cells expand a CD4+CD25+Foxp3+ Treg population via TGF-beta3.
    Shah S; Qiao L
    Eur J Immunol; 2008 Sep; 38(9):2488-98. PubMed ID: 18792402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells.
    Sonobe Y; Li H; Jin S; Kishida S; Kadomatsu K; Takeuchi H; Mizuno T; Suzumura A
    J Immunol; 2012 Mar; 188(6):2602-11. PubMed ID: 22323540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FoxP3 associates with enhancer-promoter loops to regulate T
    Ramirez RN; Chowdhary K; Leon J; Mathis D; Benoist C
    Sci Immunol; 2022 Jan; 7(67):eabj9836. PubMed ID: 35030035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C6-ceramide in combination with transforming growth factor-β enhances Treg cell differentiation and stable FoxP3 expression in vitro and in vivo.
    Kue CS; Lim HX; Jung MY; Hong HJ; Cho D; Kim TS
    Immunobiology; 2013 Jul; 218(7):952-9. PubMed ID: 23313049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function.
    Loo CS; Gatchalian J; Liang Y; Leblanc M; Xie M; Ho J; Venkatraghavan B; Hargreaves DC; Zheng Y
    Immunity; 2020 Jul; 53(1):143-157.e8. PubMed ID: 32640256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
    Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
    J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
    Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
    Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells.
    Swanson RM; Gavin MA; Escobar SS; Rottman JB; Lipsky BP; Dube S; Li L; Bigler J; Wolfson M; Arnett HA; Viney JL
    J Immunol; 2013 Mar; 190(5):2027-35. PubMed ID: 23359506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.